ArticleOncology letters2026

FBXL5 depletion as a novel strategy against osteosarcoma: Evidence for MEK/ERK inhibition and enhanced therapeutic sensitivity.

Yan-Chao Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.